BUYING GUIDE · BPC-157 · CANADA
How to Choose Research-Grade BPC-157 in Canada: A Supplier Checklist for Laboratories
Searches such as “BPC-157 Canada”, “buy BPC-157 Canada”, “BPC 157 for sale Canada” and even the misspelling “bcp157” all point to the same synthetic peptide, so the spelling on a listing says nothing about quality. This guide is for laboratory researchers sourcing research-grade material in Canada. It sets out what to check before ordering and what to ask a supplier, and it describes PurixLab’s BPC-157 + TB-500 10mg vial as one option. It is a sourcing checklist for lab work, not guidance for human or veterinary use, and it makes no claims about what the peptide does.
Start with what the material is
BPC-157 is a synthetic pentadecapeptide with the amino acid sequence GEPPPGKPADDAGLV, derived from a fragment of a gastric protein [1,2]. It remains an investigational compound. A 2026 review of its biopharmaceutical profile reports no approved formulation and no completed Phase II clinical trial [2], and a narrative review advises that it be considered investigational [3]. That has a practical consequence for buyers: there is no approved product label to lean on, so what is in the vial has to be shown by the supplier’s own analytical data.
The same narrative review notes that BPC-157 is widely available through non-regulated sources [3], and analytical laboratories have reported BPC 157 in confiscated vials [1]. Both observations point the same way: treat every listing as unverified until the evidence is in front of you.
1. Confirm the sequence, especially for blends
Ask the supplier to state the full sequence of every peptide in the vial. This matters most for blends. The name “TB-500” is used for a product in which researchers identified the N-terminal acetylated fragment 17-23 of human thymosin beta 4, written Ac-LKKTETQ [4]. That is a short fragment, not the full-length protein. A listing that only says “TB-500” or “thymosin” leaves your experiment’s identity unstated, so ask which one it is. Our article on BPC-157 and TB-500 pharmacokinetics and detection methods covers how these peptides are measured.
2. Ask for HPLC purity with the chromatogram, plus mass-spectrometry identity
A purity percentage typed into a document proves little. Ask for the HPLC chromatogram behind the number, the method, and a mass-spectrometry result showing the observed mass against the expected mass. Synthetic peptides carry predictable by-products: deletion and insertion sequences, racemised residues, oxidised side chains, dimers and residual counter-ions such as trifluoroacetate [5]. The same review notes that such impurities can distort early functional studies and lead to erroneous conclusions [5]. Our guide How to Read a Peptide COA walks through each section of a certificate of analysis and the red flags.
3. Separate purity from peptide content
HPLC purity is not the same as how much of the powder is peptide. In a study by National Research Council Canada on an angiotensin II reference material, the trifluoroacetate counter-ion alone made up nearly 25% by mass, and the assigned purity was 691 mg/g [6]. That is a different peptide, but it shows why a vial’s labelled mass and its peptide content can differ. Counter-ions can also be exchanged for others during preparation [7], so ask which salt form the material is and whether peptide content has been measured, particularly if you will prepare quantitative solutions.
4. Check form, labelling, storage and handling
Physical stability of peptides depends on factors including sequence, pH, temperature, agitation and lyophilization [8]. In practice, look for a supplier that sells a labelled lyophilized vial, states the contents per vial, and tells you to follow the label and batch documentation together with your own laboratory procedures. Be wary of listings that give improvised handling instructions. Our article How Lyophilized Peptides Degrade explains the chemistry.
5. Insist on lot numbers and dates
A certificate only describes the batch it was run on. The lot number on the document must match the lot number on your vial, and the test date and the testing laboratory should be named. If a supplier cannot tell you which batch you will receive, or the paperwork has no lot number at all, you cannot tie any result to your material. Equally, do not assume documentation exists because a listing mentions purity: ask what is available for the batch, and ask before you order.
6. Compare Canadian shipping, payment and returns
For Canadian buyers, practical questions matter as much as chemistry. Where is the stock held? Which carrier is used and is tracking provided? Is the total in Canadian dollars, with taxes shown at checkout? What payment methods are accepted, and what happens if an order arrives damaged or incorrect? A supplier that ships domestic orders from stock in Canada avoids the cross-border steps that can delay an order.
A short checklist
- The full sequence of each peptide in the vial is stated, including which TB-500 form is meant.
- HPLC chromatogram and mass-spectrometry data are available for the batch you will receive.
- The salt form and any peptide-content measurement are disclosed on request.
- The vial is labelled, lyophilized, and the supplier points you to batch documentation for storage and handling.
- Lot number, test date and testing laboratory appear on the document and match the vial.
- Price, shipping cost, carrier, tracking and returns terms are stated in Canadian dollars.
- The listing says laboratory research use only, with no usage instructions for people or animals and no health claims.
What the literature does not settle
None of the points above depend on what BPC-157 is reported to do in animal studies. The human evidence base is thin: only three pilot studies have examined it in humans, and rigorous large-scale trials are lacking [3]. The pharmacokinetic profile in humans is also described as critically undercharacterized [2]. For a laboratory buyer, this is a reason to document exactly which material, which batch and which supplier each experiment used. Our overview BPC-157 and TB-500: Preclinical Studies and the Human Data Gap covers the published evidence.
BPC-157 + TB-500 10mg at PurixLab
BPC-157 + TB-500 10mg: a labelled lyophilized research vial with BPC-157 5mg and TB-500 5mg (10mg total) per vial, C$89 per vial (CAD, before tax), supplied for laboratory research only. Product page: purixlab.com/product/bpc-157-tb-500-10mg/.
Measured against the checklist above, note that the product page lists the composition and refers to batch-specific documentation for handling and storage, but it does not currently display a certificate of analysis. If your project needs particular supporting documentation, email [email protected] before ordering and tell us what you need; we will tell you what is available for the batch.
PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.
In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.
Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Current offers and any pack pricing are shown on the product page and in your cart; offers do not stack.
For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.
Questions: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ
References
- Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. Drug Test Anal. 2017;9(10):1490-1498. PubMed 28035768 · doi:10.1002/dta.2152
- Mateescu DM, Gavrilescu DM, Constantinescu FE, et al. BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers. Pharmaceutics. 2026;18(5):625. PubMed 42198317 · PMC13210877 · doi:10.3390/pharmaceutics18050625
- McGuire FP, Martinez R, Lenz A, et al. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025;18(12):611-619. PubMed 40789979 · PMC12446177 · doi:10.1007/s12178-025-09990-7
- Esposito S, Deventer K, Goeman J, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-8. PubMed 22962027 · doi:10.1002/dta.1402
- D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PubMed 25044089 · doi:10.1016/j.jpba.2014.06.012
- Melanson JE, Thibeault MP, Stocks BB, et al. Purity assignment for peptide certified reference materials by combining qNMR and LC-MS/MS amino acid analysis results: application to angiotensin II. Anal Bioanal Chem. 2018;410(26):6719-6731. PubMed 30143839 · doi:10.1007/s00216-018-1272-7
- Roux S, Zékri E, Rousseau B, et al. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches. J Pept Sci. 2008;14(3):354-9. PubMed 18035848 · doi:10.1002/psc.951
- Zapadka KL, Becher FJ, Gomes Dos Santos AL, et al. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7(6):20170030. PubMed 29147559 · PMC5665799 · doi:10.1098/rsfs.2017.0030